NCT02784028View on ClinicalTrials.gov

Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

December 8, 2017

Conditions
Peritoneal Carcinomatosis
Interventions
OTHER

SGM-101

Administration of SGM-101 prior surgery

Trial Locations (1)

34298

Institut régional du Cancer de Montpellier, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT02784028 - Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer | Biotech Hunter | Biotech Hunter